KDL Biotech Ltd. - Research Center
532291 KOPDRUGS Group (Z) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 14 | Mar ' 13 | Sep ' 12 | Mar ' 12 | Sep ' 11 | |
|---|---|---|---|---|---|
| Sales | - | 9.12 | 11.42 | 13.19 | 13.56 |
| Operating profit | -0.61 | -0.99 | -1.81 | -0.99 | -0.85 |
| Interest | 2.45 | 3.45 | 3.41 | 3.42 | 3.33 |
| Gross profit | -2.98 | -4.25 | -5.06 | -4.11 | -4.01 |
| EPS (Rs) | -2.68 | -3.20 | -3.55 | -3.45 | -3.73 |
Half yearly
results in details
| Sep ' 14 | Mar ' 13 | Sep ' 12 | Mar ' 12 | Sep ' 11 | |
|---|---|---|---|---|---|
| Other income | 0.07 | 0.20 | 0.16 | 0.30 | 0.16 |
| Stock adjustment | - | -0.38 | - | - | - |
| Raw material | - | 0.34 | 0.60 | 0.04 | 0.25 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 0.18 | 3.90 | 5.03 | 4.95 | 4.85 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 0.43 | 6.26 | 7.60 | 9.19 | 9.31 |
| Provisions made | - | - | - | - | - |
| Depreciation | 3.46 | 3.44 | 3.46 | 4.21 | 4.95 |
| Taxation | - | - | - | - | - |
| Net profit / loss | -6.44 | -7.68 | -8.52 | -8.28 | -8.96 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | 0.03 | - |
| Equity capital | 24.04 | 24.04 | 24.04 | 24.04 | 24.04 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | 74.85 | 74.85 | 74.85 | 74.85 | 74.85 |
| Agg.of non promotoholding (%) | 31.14 | 31.14 | 31.14 | 31.14 | 31.14 |
| OPM (%) | - | -10.89 | -15.89 | -7.51 | -6.26 |
| GPM (%) | - | -45.56 | -43.73 | -30.46 | -29.23 |
| NPM (%) | - | -82.45 | -73.63 | -61.39 | -65.28 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis